Trials / Conditions / ALK-positive Non-small Cell Lung Cancer (NSCLC)
ALK-positive Non-small Cell Lung Cancer (NSCLC)
3 registered clinical trials studyying ALK-positive Non-small Cell Lung Cancer (NSCLC) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operabl NCT06785584 | Fujian Medical University Union Hospital | Phase 4 |
| Terminated | A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer NCT03131206 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Available | Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumo NCT06834074 | Nuvalent Inc. | — |